Ad is loading...
MENU

IBRX ImmunityBio Forecast, Technical & Fundamental Analysis

a producer of cancer treatment products

Industry Biotechnology
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

IBRX is expected to report earnings to rise 67.86% to -23 cents per share on August 09

ImmunityBio IBRX Stock Earnings Reports
Q2'23
Est.
$-0.23
Q3'24
Beat
by $0.04
Q2'24
Est.
$-0.20
Q1'24
Beat
by $0.01
Q4'23
Missed
by $0.17
The last earnings report on November 12 showed earnings per share of -14 cents, beating the estimate of -18 cents. With 3.42M shares outstanding, the current market capitalization sits at 3.55B.
A.I. Advisor
published General Information

General Information

a producer of cancer treatment products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWLIX48.420.48
+1.00%
Hotchkis & Wiley Large Cap Fdml Value I
TCCHX25.080.18
+0.72%
Nuveen Social Choice LwCrbn Eq I
RICAX61.500.27
+0.44%
American Funds Invmt Co of Amer R1
RTNCX11.530.02
+0.17%
Russell Inv Tax-Managed Intl Eq C
IGIUX100.660.16
+0.16%
Integrity Growth & Income Fund C

IBRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
+1.29%
AXON - IBRX
48%
Loosely correlated
+0.90%
ARRY - IBRX
41%
Loosely correlated
+4.74%
AMRN - IBRX
37%
Loosely correlated
+4.52%
RXRX - IBRX
37%
Loosely correlated
-0.87%
VCYT - IBRX
35%
Loosely correlated
+1.67%
More